David J Chambers Selected Research

Induced Heart Arrest (Cardioplegia)

1/2022	Normothermic blood polarizing versus depolarizing cardioplegia in a porcine model of cardiopulmonary bypass.
12/2019	St Thomas' Hospital polarizing blood cardioplegia improves hemodynamic recovery in a porcine model of cardiopulmonary bypass.
1/2019	Left ventricular dysfunction after two hours of polarizing or depolarizing cardioplegic arrest in a porcine model.
1/2018	Efficacy of esmolol cardioplegia during hypothermic ischaemia.
7/2017	Myocardial energy metabolism and ultrastructure with polarizing and depolarizing cardioplegia in a porcine model.
7/2016	Myocardial function after polarizing versus depolarizing cardiac arrest with blood cardioplegia in a porcine model of cardiopulmonary bypass.
1/2013	Future perspective of cardioplegic protection in cardiac surgery.
9/2012	Ischaemic postconditioning: does cardioplegia influence protection?
7/2010	Cardioplegia and cardiac surgery: pharmacological arrest and cardioprotection during global ischemia and reperfusion.
4/2009	Targeting for cardioplegia: arresting agents and their safety.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David J Chambers Research Topics

Disease

7	Heart Arrest (Cardiac Arrest) 01/2022 - 02/2003
6	Ischemia 12/2019 - 08/2002
2	Stroke (Strokes) 01/2019 - 07/2016
2	Hypothermia 01/2018 - 06/2017
1	Thrombocytopenia (Thrombopenia) 01/2019
1	Lung Injury 11/2014
1	Lung Diseases (Lung Disease) 11/2014
1	Infarction (Infarctions) 09/2012
1	Sepsis (Septicemia) 06/2009
1	Movement Disorders (Movement Disorder) 01/2009
1	Nocturia 01/2009
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2009
1	Orthostatic Hypotension (Postural Hypotension) 01/2009
1	Reperfusion Injury 01/2005
1	Hyperkalemia 08/2002

Drug/Important Bio-Agent (IBA)

3	esmolol (Brevibloc)FDA LinkGeneric 01/2018 - 08/2002
2	SolutionsIBA 01/2018 - 08/2002
2	St. Thomas' Hospital cardioplegic solutionIBA 07/2017 - 09/2012
2	MagnesiumIBA 07/2017 - 09/2012
2	Oxygen (Dioxygen)IBA 06/2017 - 08/2002
2	PotassiumIBA 01/2013 - 12/2005
1	MicroRNAs (MicroRNA)IBA 12/2019
1	Heparin (Liquaemin)FDA LinkGeneric 01/2019
1	Cardioplegic SolutionsIBA 07/2017
1	Adenosine (Adenocard)FDA LinkGeneric 07/2017
1	Phosphates (Orthophosphate)IBA 07/2017
1	p38 Mitogen-Activated Protein KinasesIBA 11/2014
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 11/2014
1	Theophylline (Theon)FDA LinkGeneric 11/2014
1	Mitogen-Activated Protein Kinase 3IBA 11/2014
1	Mitogen-Activated Protein KinasesIBA 11/2014
1	AntibodiesIBA 06/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2009
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2009
1	Monoamine Oxidase Inhibitors (Monoamine Oxidase Inhibitor)IBA 01/2009
1	Serotonin and Noradrenaline Reuptake InhibitorsIBA 01/2009
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2009
1	Antidepressive Agents (Antidepressants)IBA 01/2009
1	Serotonin (5 Hydroxytryptamine)IBA 01/2009
1	Glyburide (Glibenclamide)FDA LinkGeneric 12/2005
1	chelerythrineIBA 12/2005
1	Protein Kinase CIBA 12/2005
1	Adenosine Triphosphate (ATP)IBA 12/2005
1	mitochondrial K(ATP) channelIBA 12/2005
1	P-SelectinIBA 01/2005
1	Creatine Kinase (Creatine Phosphokinase)IBA 04/2004
1	ChloridesIBA 04/2004
1	CalciumIBA 02/2003
1	Krebs-Henseleit solutionIBA 08/2002
1	NitrogenIBA 08/2002
1	Carbon DioxideIBA 08/2002

Therapy/Procedure

11	Induced Heart Arrest (Cardioplegia) 01/2022 - 08/2002
7	Cardiopulmonary Bypass (Heart-Lung Bypass) 01/2022 - 01/2005
1	Heart Transplantation (Grafting, Heart) 06/2017